The main molecular targets in breast cancer pathogenesis are estrogen receptor alpha (ERα), which is expressed in approximately 75% of invasive breast cancers and human epidermal growth factor receptor 2 (ERBB2/HER2), amplified or overexpressed in approximately 15% of breast cancers [3]. This evidence concerns the gene ERBB2 and invasive breast carcinoma.